Hope for blood cancer patients

Research into stems cells is yielding results that could change the treatment of certain cancers

By ADAM GONN
March 6, 2013 12:32
2 minute read.
Gamida Cell studying 521

Gamida Cell studying 521. (photo credit: Courtesy Gamida Cell)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Close to half the patients suffering from illnesses such as leukemia and lymphoma are treated by undergoing bone marrow transplantations, in which damaged or dead marrow is replaced with bone marrow from a healthy individual, usually a family member.

Leukemia and other blood diseases are also often treated with chemotherapy, which destroys the cancer cells in the bone marrow.

Read More...

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content